Sipeki Nóra
DE >
ÁOKDivision of Gastroenterology
PhD hallgató 2012-2015
DE >
ÁOKrezidens, majd szakorvosjelölt 2015-2019
DE >
ÁOKbelgyógyász szakorvos, postdoc kutató 2019-2021
DE >
ÁOKbelgyógyász-gasztroenterológus szakorvos, postdoc kutató, tanársegéd 2021-
Name: Sipeki Nóra
Affiliation: - Debreceni Egyetem. Általános Orvostudományi Kar. Belgyógyászati Intézet. Gastroenterológiai Tanszék / University of Debrecen. Faculty of Medicine. Department of Internal Medicine. Division of Gastroenterology
- Debreceni Egyetem. A DE Központi Egységei. Klinikai Központ. Gasztroenterológiai Klinika / University of Debrecen. Central Units of UD. Medical Center.
Degree
- PhD, Debreceni Egyetem Orvostudományi Doktori Tanács (2016)
Publication list
2024
Fehér, K.,
Tornai, D.,
Vitális, Z.,
Dávida, L.,
Sipeki, N.,
Papp, M.:
Non-pancreatic hyperlipasemia: a puzzling clinical entity.
World J. Gastroenterol. 30 (19), 2538-2552, 2024.
Journal metrics:
Q1 Gastroenterology (2023)
Q1 Medicine (miscellaneous) (2023)
Schregel, I.,
Papp, M.,
Sipeki, N.,
Kováts, P.,
Taubert, R.,
Engel, B.,
Campos-Murguia, A.,
Dalekos, G.,
Gatselis, N.,
Zachou, K.,
Milkiewicz, P.,
Janik, M.,
Raszeja-Wyszomirska, J.,
Ytting, H.,
Braun, F.,
Casar, C.,
Sebode, M.,
Lohse, A.,
Schramm, C.,
European Reference Network (ERN) RARE-LIVER:
Unmet needs in autoimmune hepatitis: results of the prospective multicentre European Reference Network Registry (R-LIVER).
Liver Int. 44 (10), 2687-2699, 2024.
2023
Sipeki, N.,
Kováts, P.,
Deutschmann, C.,
Schierack, P.,
Roggenbuck, D.,
Papp, M.:
Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies.
World J. Gastroenterol. 29 (42), 5728-5750, 2023.
Journal metrics:
Q1 Gastroenterology
Q1 Medicine (miscellaneous)
2022
2021
Tornai, D.,
Antal-Szalmás, P.,
Tornai, T.,
Papp, M.,
Tornai, I.,
Sipeki, N.,
Janka, T.,
Balogh, B.,
Vitális, Z.:
Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study.
BMC Gastroenterol. 21 (1), 1-13, 2021.
Journal metrics:
Q2 Gastroenterology
Q2 Medicine (miscellaneous)
Tornai, D.,
Vitális, Z.,
Jónás, A.,
Janka, T.,
Földi, I.,
Tornai, T.,
Sipeki, N.,
Csillag, A.,
Balogh, B.,
Sümegi, A.,
Földesi, R.,
Papp, M.,
Antal-Szalmás, P.:
Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality.
Clin. Res. Hepatol. Gastroenterol. 45 (5), 1-12, 2021.
Journal metrics:
Q3 Gastroenterology
Q3 Hepatology
2020
Nagy, G.,
Csípő, I.,
Tarr, T.,
Szűcs, G.,
Szántó, A.,
Bubán, T.,
Sipeki, N.,
Szekanecz, Z.,
Papp, M.,
Kappelmayer, J.,
Antal-Szalmás, P.:
Anti-neutrophil cytoplasmic antibody testing by indirect immunofluorescence: computer-aided versus conventional microscopic evaluation of routine diagnostic samples from patients with vasculitis or other inflammatory diseases.
Clin. Chim. Acta. 511 117-124, 2020.
Journal metrics:
Q2 Biochemistry
Q2 Biochemistry (medical)
Q2 Clinical Biochemistry
Q2 Medicine (miscellaneous)
Balogh, B.,
Pályu, E.,
Villám, B.,
Sipeki, N.,
Vitális, Z.,
Kovács, G.,
Tornai, I.,
Papp, M.:
A primer biliaris cholangitis (PBC) diagnosztikája és kezelése: az Európai Májkutató Társaság Klinikai Gyakorlati Útmutatója nyomán.
Cent. Eur. J. Gastroenterol. Hepatol. 6 (2), 124-146, 2020.
Sipeki, N.,
Kováts, P.,
Balogh, B.,
Shums, Z.,
Norman, G.,
Antal-Szalmás, P.,
Papp, M.:
Gut barrier failure biomarkers in IBD: is there anything new beyond "The Wall"?.
J. Crohns Colitis. 14 (Suppl1), S296, 2020.
Pape, S.,
Gevers, T.,
Vrolijk, J.,
van, H.,
Bouma, G.,
van, N.,
Taubert, R.,
Jaeckel, E.,
Manns, M.,
Papp, M.,
Sipeki, N.,
Stickel, F.,
Efe, C.,
Ozaslan, E.,
Purnak, T.,
Nevens, F.,
Kessener, D.,
Kahraman, A.,
Wedemeyer, H.,
Hartl, J.,
Schramm, C.,
Lohse, A.,
Heneghan, M.,
Drenth, J.:
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation.
Liver Int. 40 (9), 2164-2171, 2020.
Pape, S.,
Gevers, T.,
Maarten Vrolijk, J.,
Hoek, B.,
Bouma, G.,
Nieuwkerk, C.,
Taubert, R.,
Jaeckel, E.,
Manns, M.,
Papp, M.,
Sipeki, N.,
Stickel, F.,
Efe, C.,
Ozaslan, E.,
Purnak, T.,
Nevens, F.,
Kessener, D.,
Kahraman, A.,
Wedemeyer, H.,
Hartl, J.,
Schramm, C.,
Lohse, A.,
Drenth, J.,
Heneghan, M.:
Rapid Response to Treatment of Autoimmune Hepatitis Associated with Remission at 6 and 12 Months.
Clin. Gastroenterol. Hepatol. 18 (7), 1609-1617, 2020.
Journal metrics:
D1 Gastroenterology
Q1 Hepatology
2019
Deutschmann, C.,
Sowa, M.,
Murugaiyan, J.,
Roesler, U.,
Röber, N.,
Conrad, K.,
Laass, M.,
Bogdanos, D.,
Sipeki, N.,
Papp, M.,
Rödiger, S.,
Roggenbuck, D.,
Schierack, P.:
Identification of Chitinase-3-like protein 1 as a novel neutrophil antigenic target in Crohn's disease.
J. Crohns Colitis. 13 (7), 894-904, 2019.
Journal metrics:
D1 Gastroenterology
D1 Medicine (miscellaneous)
2018
Tornai, T.,
Tornai, D.,
Sipeki, N.,
Tornai, I.,
Alsulaimani, R.,
Fechner, K.,
Roggenbuck, D.,
Norman, G.,
Veres, G.,
Pár, G.,
Pár, A.,
Szalay, F.,
Lakatos, P.,
Antal-Szalmás, P.,
Papp, M.:
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis.
Sci. Rep. 8 (1), 1-11, 2018.
Kovács, G.,
Sipeki, N.,
Suga, B.,
Tornai, T.,
Fechner, K.,
Norman, G.,
Shums, Z.,
Antal-Szalmás, P.,
Papp, M.:
Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients.
PLoS One. 13 (3), 1-18, 2018.
Journal metrics:
Q1 Agricultural and Biological Sciences (miscellaneous)
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)
2017
Földi, I.,
Tornai, T.,
Tornai, D.,
Sipeki, N.,
Vitális, Z.,
Tornai, I.,
Dinya, T.,
Antal-Szalmás, P.,
Papp, M.:
Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections.
Liver Int. 37 (7), 1023-1031, 2017.
Papp, M.,
Tornai, T.,
Vitális, Z.,
Tornai, I.,
Sipeki, N.,
Balogh, B.,
Antal-Szalmás, P.,
Trebica, J.:
PREDICT (Predicting Acute-on- Chronic Liver Failure in Cirrhosis) multicentrikus európai prospektív obszervációs tanulmány: EASL-CLIF Consortium, 2017-2018.
CEU-JGH. 3 (2), 151-154, 2017.
2016
Tornai, T.,
Vitális, Z.,
Sipeki, N.,
Dinya, T.,
Tornai, D.,
Antal-Szalmás, P.,
Karányi, Z.,
Tornai, I.,
Papp, M.:
Macrophage activation marker, soluble CD163 is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
Liver Int. 36 (11), 1628-1638, 2016.
2015
Sipeki, N.,
Dávida, L.,
Pályu, E.,
Altorjay, I.,
Hársfalvi, J.,
Antal-Szalmás, P.,
Szabó, Z.,
Veres, G.,
Shums, Z.,
Norman, G.,
Lakatos, P.,
Papp, M.:
Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
World J. Gastroenterol. 21 (22), 6952-6964, 2015.
Journal metrics:
Q1 Gastroenterology
Q1 Medicine (miscellaneous)
Papp, M.,
Sipeki, N.,
Tornai, T.,
Altorjay, I.,
Norman, G.,
Shums, Z.,
Roggenbuck, D.,
Fechner, K.,
Stocker, W.,
Antal-Szalmás, P.,
Veres, G.,
Lakatos, P.:
Rediscovery of the anti-pancreatic antibodies and evaluation of their prognostic value in a prospective clinical cohort of Crohn's patients: the importance of specific target antigens (GP2 and CUZD1).
J. Crohns Colitis. 9 (8), 659-668, 2015.
Journal metrics:
D1 Gastroenterology
D1 Medicine (miscellaneous)
Lakatos, P.,
Sipeki, N.,
Kovács, G.,
Pályu, E.,
Norman, G.,
Shums, Z.,
Golovics, P.,
Lovász, B.,
Antal-Szalmás, P.,
Papp, M.:
Risk matrix for prediction of disease progression in a referral cohort of patients with Crohn's disease.
J. Crohns. Colitis. 9 (10), 891-898, 2015.
Journal metrics:
D1 Gastroenterology
D1 Medicine (miscellaneous)
Tornai, T.,
Tornai, D.,
Sipeki, N.,
Földi, I.,
Dinya, T.,
Vitális, Z.,
Antal-Szalmás, P.,
Tornai, I.,
Papp, M.:
Soluble CD163 (SCD163) is a marker of infection in patients with cirrhosis and acute decompensation and an independent predictor of the short-term mortality.
J. Hepatol. 62 (Supplement), S368, 2015.
2024
Fehér, K.,
Tornai, D.,
Vitális, Z.,
Dávida, L.,
Sipeki, N.,
Papp, M.:
Non-pancreatic hyperlipasemia: a puzzling clinical entity.
World J. Gastroenterol. 30 (19), 2538-2552, 2024.
Journal metrics:
Q1 Gastroenterology (2023)
Q1 Medicine (miscellaneous) (2023)
Schregel, I.,
Papp, M.,
Sipeki, N.,
Kováts, P.,
Taubert, R.,
Engel, B.,
Campos-Murguia, A.,
Dalekos, G.,
Gatselis, N.,
Zachou, K.,
Milkiewicz, P.,
Janik, M.,
Raszeja-Wyszomirska, J.,
Ytting, H.,
Braun, F.,
Casar, C.,
Sebode, M.,
Lohse, A.,
Schramm, C.,
European Reference Network (ERN) RARE-LIVER:
Unmet needs in autoimmune hepatitis: results of the prospective multicentre European Reference Network Registry (R-LIVER).
Liver Int. 44 (10), 2687-2699, 2024.
2023
Sipeki, N.,
Kováts, P.,
Deutschmann, C.,
Schierack, P.,
Roggenbuck, D.,
Papp, M.:
Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies.
World J. Gastroenterol. 29 (42), 5728-5750, 2023.
Journal metrics:
Q1 Gastroenterology
Q1 Medicine (miscellaneous)
2022
2021
Tornai, D.,
Antal-Szalmás, P.,
Tornai, T.,
Papp, M.,
Tornai, I.,
Sipeki, N.,
Janka, T.,
Balogh, B.,
Vitális, Z.:
Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study.
BMC Gastroenterol. 21 (1), 1-13, 2021.
Journal metrics:
Q2 Gastroenterology
Q2 Medicine (miscellaneous)
Tornai, D.,
Vitális, Z.,
Jónás, A.,
Janka, T.,
Földi, I.,
Tornai, T.,
Sipeki, N.,
Csillag, A.,
Balogh, B.,
Sümegi, A.,
Földesi, R.,
Papp, M.,
Antal-Szalmás, P.:
Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality.
Clin. Res. Hepatol. Gastroenterol. 45 (5), 1-12, 2021.
Journal metrics:
Q3 Gastroenterology
Q3 Hepatology
2020
Nagy, G.,
Csípő, I.,
Tarr, T.,
Szűcs, G.,
Szántó, A.,
Bubán, T.,
Sipeki, N.,
Szekanecz, Z.,
Papp, M.,
Kappelmayer, J.,
Antal-Szalmás, P.:
Anti-neutrophil cytoplasmic antibody testing by indirect immunofluorescence: computer-aided versus conventional microscopic evaluation of routine diagnostic samples from patients with vasculitis or other inflammatory diseases.
Clin. Chim. Acta. 511 117-124, 2020.
Journal metrics:
Q2 Biochemistry
Q2 Biochemistry (medical)
Q2 Clinical Biochemistry
Q2 Medicine (miscellaneous)
Balogh, B.,
Pályu, E.,
Villám, B.,
Sipeki, N.,
Vitális, Z.,
Kovács, G.,
Tornai, I.,
Papp, M.:
A primer biliaris cholangitis (PBC) diagnosztikája és kezelése: az Európai Májkutató Társaság Klinikai Gyakorlati Útmutatója nyomán.
Cent. Eur. J. Gastroenterol. Hepatol. 6 (2), 124-146, 2020.
Sipeki, N.,
Kováts, P.,
Balogh, B.,
Shums, Z.,
Norman, G.,
Antal-Szalmás, P.,
Papp, M.:
Gut barrier failure biomarkers in IBD: is there anything new beyond "The Wall"?.
J. Crohns Colitis. 14 (Suppl1), S296, 2020.
Pape, S.,
Gevers, T.,
Vrolijk, J.,
van, H.,
Bouma, G.,
van, N.,
Taubert, R.,
Jaeckel, E.,
Manns, M.,
Papp, M.,
Sipeki, N.,
Stickel, F.,
Efe, C.,
Ozaslan, E.,
Purnak, T.,
Nevens, F.,
Kessener, D.,
Kahraman, A.,
Wedemeyer, H.,
Hartl, J.,
Schramm, C.,
Lohse, A.,
Heneghan, M.,
Drenth, J.:
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation.
Liver Int. 40 (9), 2164-2171, 2020.
Pape, S.,
Gevers, T.,
Maarten Vrolijk, J.,
Hoek, B.,
Bouma, G.,
Nieuwkerk, C.,
Taubert, R.,
Jaeckel, E.,
Manns, M.,
Papp, M.,
Sipeki, N.,
Stickel, F.,
Efe, C.,
Ozaslan, E.,
Purnak, T.,
Nevens, F.,
Kessener, D.,
Kahraman, A.,
Wedemeyer, H.,
Hartl, J.,
Schramm, C.,
Lohse, A.,
Drenth, J.,
Heneghan, M.:
Rapid Response to Treatment of Autoimmune Hepatitis Associated with Remission at 6 and 12 Months.
Clin. Gastroenterol. Hepatol. 18 (7), 1609-1617, 2020.
Journal metrics:
D1 Gastroenterology
Q1 Hepatology
2019
Deutschmann, C.,
Sowa, M.,
Murugaiyan, J.,
Roesler, U.,
Röber, N.,
Conrad, K.,
Laass, M.,
Bogdanos, D.,
Sipeki, N.,
Papp, M.,
Rödiger, S.,
Roggenbuck, D.,
Schierack, P.:
Identification of Chitinase-3-like protein 1 as a novel neutrophil antigenic target in Crohn's disease.
J. Crohns Colitis. 13 (7), 894-904, 2019.
Journal metrics:
D1 Gastroenterology
D1 Medicine (miscellaneous)
2018
Tornai, T.,
Tornai, D.,
Sipeki, N.,
Tornai, I.,
Alsulaimani, R.,
Fechner, K.,
Roggenbuck, D.,
Norman, G.,
Veres, G.,
Pár, G.,
Pár, A.,
Szalay, F.,
Lakatos, P.,
Antal-Szalmás, P.,
Papp, M.:
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis.
Sci. Rep. 8 (1), 1-11, 2018.
Kovács, G.,
Sipeki, N.,
Suga, B.,
Tornai, T.,
Fechner, K.,
Norman, G.,
Shums, Z.,
Antal-Szalmás, P.,
Papp, M.:
Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients.
PLoS One. 13 (3), 1-18, 2018.
Journal metrics:
Q1 Agricultural and Biological Sciences (miscellaneous)
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)
2017
Földi, I.,
Tornai, T.,
Tornai, D.,
Sipeki, N.,
Vitális, Z.,
Tornai, I.,
Dinya, T.,
Antal-Szalmás, P.,
Papp, M.:
Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections.
Liver Int. 37 (7), 1023-1031, 2017.
Papp, M.,
Tornai, T.,
Vitális, Z.,
Tornai, I.,
Sipeki, N.,
Balogh, B.,
Antal-Szalmás, P.,
Trebica, J.:
PREDICT (Predicting Acute-on- Chronic Liver Failure in Cirrhosis) multicentrikus európai prospektív obszervációs tanulmány: EASL-CLIF Consortium, 2017-2018.
CEU-JGH. 3 (2), 151-154, 2017.
2016
Tornai, T.,
Vitális, Z.,
Sipeki, N.,
Dinya, T.,
Tornai, D.,
Antal-Szalmás, P.,
Karányi, Z.,
Tornai, I.,
Papp, M.:
Macrophage activation marker, soluble CD163 is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
Liver Int. 36 (11), 1628-1638, 2016.
2015
Sipeki, N.,
Dávida, L.,
Pályu, E.,
Altorjay, I.,
Hársfalvi, J.,
Antal-Szalmás, P.,
Szabó, Z.,
Veres, G.,
Shums, Z.,
Norman, G.,
Lakatos, P.,
Papp, M.:
Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
World J. Gastroenterol. 21 (22), 6952-6964, 2015.
Journal metrics:
Q1 Gastroenterology
Q1 Medicine (miscellaneous)
Papp, M.,
Sipeki, N.,
Tornai, T.,
Altorjay, I.,
Norman, G.,
Shums, Z.,
Roggenbuck, D.,
Fechner, K.,
Stocker, W.,
Antal-Szalmás, P.,
Veres, G.,
Lakatos, P.:
Rediscovery of the anti-pancreatic antibodies and evaluation of their prognostic value in a prospective clinical cohort of Crohn's patients: the importance of specific target antigens (GP2 and CUZD1).
J. Crohns Colitis. 9 (8), 659-668, 2015.
Journal metrics:
D1 Gastroenterology
D1 Medicine (miscellaneous)
Lakatos, P.,
Sipeki, N.,
Kovács, G.,
Pályu, E.,
Norman, G.,
Shums, Z.,
Golovics, P.,
Lovász, B.,
Antal-Szalmás, P.,
Papp, M.:
Risk matrix for prediction of disease progression in a referral cohort of patients with Crohn's disease.
J. Crohns. Colitis. 9 (10), 891-898, 2015.
Journal metrics:
D1 Gastroenterology
D1 Medicine (miscellaneous)
Tornai, T.,
Tornai, D.,
Sipeki, N.,
Földi, I.,
Dinya, T.,
Vitális, Z.,
Antal-Szalmás, P.,
Tornai, I.,
Papp, M.:
Soluble CD163 (SCD163) is a marker of infection in patients with cirrhosis and acute decompensation and an independent predictor of the short-term mortality.
J. Hepatol. 62 (Supplement), S368, 2015.
2014
2013
Papp, M.,
Sipeki, N.,
Vitális, Z.,
Tornai, T.,
Altorjay, I.,
Tornai, I.,
Udvardy, M.,
Fechner, K.,
Jacobsen, S.,
Teegen, B.,
Sümegi, A.,
Veres, G.,
Lakatos, P.,
Kappelmayer, J.,
Antal-Szalmás, P.:
High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.
J. Hepatol. 59 (3), 457-466, 2013.
Show all
updated: 2025-02-02, 01:19
